摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S,2S,8aS)-1,2-Bis<(tert-butyldiphenylsilyl)oxy>octahydroindolizine | 160208-49-1

中文名称
——
中文别名
——
英文名称
(1S,2S,8aS)-1,2-Bis<(tert-butyldiphenylsilyl)oxy>octahydroindolizine
英文别名
[(1S,2S,8aS)-1-[tert-butyl(diphenyl)silyl]oxy-1,2,3,5,6,7,8,8a-octahydroindolizin-2-yl]oxy-tert-butyl-diphenylsilane
(1S,2S,8aS)-1,2-Bis<(tert-butyldiphenylsilyl)oxy>octahydroindolizine化学式
CAS
160208-49-1
化学式
C40H51NO2Si2
mdl
——
分子量
634.021
InChiKey
VZRYZNCCHUQVGO-QXUSSCGESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.74
  • 重原子数:
    45
  • 可旋转键数:
    10
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    21.7
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1S,2S,8aS)-1,2-Bis<(tert-butyldiphenylsilyl)oxy>octahydroindolizine氢氟酸 作用下, 以 乙腈 为溶剂, 反应 48.0h, 以70%的产率得到(+)-lentiginosine
    参考文献:
    名称:
    立体选择性手性硝酮环加成反应合成香豆苷和应变螺旋螺异唑烷的热重排
    摘要:
    报告了Lentiginosine(3)的总合成。该策略基于将TBDPS保护的3,4-二羟基吡咯啉N-氧化物的1,3-偶极环加成至亚甲基环丙烷,然后将所得的螺环丙烷异恶唑烷进行热重排,以得到官能化的吲哚并立定骨架。该化合物的[α] D值与报道的天然异构体相同,但符号相反,但具有相同的绝对构型。
    DOI:
    10.1016/s0040-4039(00)76008-4
  • 作为产物:
    描述:
    (3S,4S)-3,4-Bis<(tert-butyldiphenylsilyl)oxy>-N-benzylpyrrolidine 在 palladium dihydroxide sodium tetrahydroborate 、 selenium(IV) oxide 、 3 A molecular sieve 、 氢气双氧水 作用下, 以 甲醇丙酮 、 xylene 、 为溶剂, 20.0~35.0 ℃ 、413.69 kPa 条件下, 反应 277.67h, 生成 (1S,2S,8aS)-1,2-Bis<(tert-butyldiphenylsilyl)oxy>octahydroindolizine
    参考文献:
    名称:
    Assignment of the Absolute Configuration of Natural Lentiginosine by Synthesis and Enzymic Assays of Optically Pure (+) and (-)-Enantiomers
    摘要:
    The structure and absolute configuration of natural lentiginosine isolated from plant sources was determined to be (1S,2S,8aS)-1,2-dihydroxyindolizidine ((+)-4) on the basis of the synthesis of both enantiomers (+)-4 and (-)-4 and their inhibition of amyloglucosidases. Alkaloid (+)-4 was derived from (L)-(+)-tartaric acid via a highly stereo- and regioselective 1,3-dipolar cycloaddition of (3S,4S)-3 ,4-bis[(tert-butyldiphenylsilyl)oxy]-1-pyrroline N-oxide to methylenecyclopropane, followed by thermal rearrangement of the adduct into (1S,2S,8aS)-1,2-[(tert-butyldiphenylsily)oxy]octahydroindolizin-7-one. The enantiomer (-)-4 was derived in the same way from (D)-(-)-tartaric acid. Both (+)-4 and (-)-4 displayed inhibition specificity for amyloglucosidases, being inactive toward 17 other glycosidases. With amyloglucosidase from Aspergillus niger, synthetic (+)-4 displayed inhibition (K-i = 2 mu M) 5 times stronger than that reported for natural lentiginosine, 35 times that measured for (-)-4, and twice that of castanospermine. Alkaloid (+)-4 is thus the most potent and specific competitive inhibitor of amyloglucosidases among azasugars and their analogues.
    DOI:
    10.1021/jo00126a033
点击查看最新优质反应信息

文献信息

  • Synthesis of lentiginosine by stereoselective chiral nitrone cycloaddition and thermal rearrangement of strained spiroisoxazolidine
    作者:Franca M. Cordero、Stefano Cicchi、Andrea Goti、Alberto Brandi
    DOI:10.1016/s0040-4039(00)76008-4
    日期:1994.1
    The total synthesis of Lentiginosine (3) is reported. The strategy is based on the 1,3-dipolar cycloaddition of a TBDPS protected 3,4-dihydroxypyrroline N-oxide to methylenecyclopropane followed by the thermal rearrangement of the resulting spirocyclopropaneisoxazolidine to give the functionalised indolizidine skeleton. The compound shows an [α]D value identical, but opposite in sign, with that reported
    报告了Lentiginosine(3)的总合成。该策略基于将TBDPS保护的3,4-二羟基吡咯啉N-氧化物的1,3-偶极环加成至亚甲基环丙烷,然后将所得的螺环丙烷异恶唑烷进行热重排,以得到官能化的吲哚并立定骨架。该化合物的[α] D值与报道的天然异构体相同,但符号相反,但具有相同的绝对构型。
  • Assignment of the Absolute Configuration of Natural Lentiginosine by Synthesis and Enzymic Assays of Optically Pure (+) and (-)-Enantiomers
    作者:Alberto Brandi、Stefano Cicchi、Franca M. Cordero、Roberta Frignoli、Andrea Goti、Sylviane Picasso、Pierre Vogel
    DOI:10.1021/jo00126a033
    日期:1995.10
    The structure and absolute configuration of natural lentiginosine isolated from plant sources was determined to be (1S,2S,8aS)-1,2-dihydroxyindolizidine ((+)-4) on the basis of the synthesis of both enantiomers (+)-4 and (-)-4 and their inhibition of amyloglucosidases. Alkaloid (+)-4 was derived from (L)-(+)-tartaric acid via a highly stereo- and regioselective 1,3-dipolar cycloaddition of (3S,4S)-3 ,4-bis[(tert-butyldiphenylsilyl)oxy]-1-pyrroline N-oxide to methylenecyclopropane, followed by thermal rearrangement of the adduct into (1S,2S,8aS)-1,2-[(tert-butyldiphenylsily)oxy]octahydroindolizin-7-one. The enantiomer (-)-4 was derived in the same way from (D)-(-)-tartaric acid. Both (+)-4 and (-)-4 displayed inhibition specificity for amyloglucosidases, being inactive toward 17 other glycosidases. With amyloglucosidase from Aspergillus niger, synthetic (+)-4 displayed inhibition (K-i = 2 mu M) 5 times stronger than that reported for natural lentiginosine, 35 times that measured for (-)-4, and twice that of castanospermine. Alkaloid (+)-4 is thus the most potent and specific competitive inhibitor of amyloglucosidases among azasugars and their analogues.
查看更多

同类化合物

长春内日啶 钩藤碱e 钩藤碱d 钩藤碱A 钩藤碱 C 钩藤碱 虎皮楠生物碱B 甲基二氯镓 流涎胺 栗精胺 柯诺辛B 柯诺辛 恩卡林碱 F 异钩藤碱 异帽叶碱 异去氢钩藤碱 帽柱叶碱 四氢-吲哚嗪-1,3-二酮 去氢钩藤碱 卡拉巴宾 六氢吲嗪-8-酮 六氢吲哚嗪-3,7-二酮 六氢-5(1H)-吲嗪硫酮 六氢-3(2H)-吲嗪硫酮 八氢吲嗪 八氢-6,7-吲嗪二醇 八倾吲嗪三醇 二环[2.2.1]庚烷-2-醇,3-(二甲氨基)-,[1S-(内,内)]-(9CI) 丙酸,2,2-二甲基-,八氢-7,8-二羟基-1,6-中氮茚二基酯,1S-(1.α.,6.β.,7.α.,8.β.,8a.β.)- 一叶萩碱 一叶秋碱 α.-塔洛-九吡喃糖,1,6:2,3-二脱水-4,7,8,9-四脱氧- [(1S,6S,7S,8R,8aR)-1,7,8-三羟基-1,2,3,5,6,7,8,8a-八氢吲嗪-6-基] 丁酸酯 N-[(1S,6S,7R,8R,8aR)-1,7,8-三羟基辛氢-6-吲哚嗪基]乙酰胺 8a-乙炔基-2,3,5,6,7,8-六氢-1H-吲嗪 8-氨基-3-氧代八氢-1-吲嗪羧酸 8-中氮茚醇,八氢-1,6,7-三(苯基甲氧基)-,1S-(1.α.,6.β.,7.α.,8.β.,8a.β.)- 6,7-二羟基苦马豆素 5(1H)-中氮茚酮,六氢-,(R)- 4-氨基-1H-苯并咪唑-6-羧酸 2-甲基-5-氧代八氢-3-吲嗪甲醛 1-甲基八氢-1-吲哚嗪并l 1,7,8-中氮茚三醇,八氢-6-(1-甲基丙基)氨基- 1,6,7-中氮茚三醇,八氢-8-甲氧基-,1S-(1.α.,6.β.,7.α.,8.β.,8a.β.)- 1,2-异亚丙基苦马豆素 (八氢吲哚啉-8-基)-甲醇 (R)-12-羟基十八烷酸 (8aS)-六氢-5,8-吲嗪二酮 (6S,7R,8R,8aR)-1,2,3,5,6,7,8,8a-八氢吲嗪-6,7,8-三醇 (6R,8AS)-6-(8-氨基-1-溴咪唑并[1,5-A]吡嗪-3-基)六氢中氮-3(2H)-酮